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Plain English summary
As much as 85 % of health research is believed to be wasted because it is not published or reported, the design is
poor or does not consider what is already known in the topic area. Although a great deal of work has been done
in the UK to reduce research waste, the role of patients and the public has not been discussed.
This paper describes a survey, on the role of patients in reducing research waste, which was carried out as part of
a larger piece of work on reducing waste in healthcare. The study found that patients were interested in reducing
research waste. The key roles they play in research, for example being co-applicants for funding, members of
project teams, co-researchers, means they have some shared responsibility for making sure the quality of research
is high. This includes finding out what is already known about a topic and getting the study design right before
seeking funding, publishing and reporting the results when the study is finished. Recognising where waste happens
is part of good management of a research study.
Abstract
Background Eighty five per cent of health research expenditure is potentially wasted due to failure to publish
research, unclear reporting of research that is published, and the failure of new research studies to systematically
review previous research in the same topic area, poor study design and conduct. A great deal of progress has been
made to address this issue but the role of patients and the public has not been considered.
Main A small survey was undertaken, as part of a larger programme of work on reducing health and care waste, to
understand the role of patients in reducing research waste. The study showed that patients are interested in this
issue particularly in relation to the prioritisation of research and patient and public involvement.
Conclusions Patients undertake key roles in the research process including co-applicancy, project management, or
as co-researchers. This brings responsibility for ensuring high quality research and value for money. Responsibility
for recognition of the potential for wasteful practices is part of the conduct and operation of research studies.
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Introduction
Creating and enhancing value within the Research and
Development (R and D) process through the reduction
of waste has been a recurrent theme in health research
as illustrated by the Lancet series of articles in 2009 and
2014 and more recent publications in 2016. It was also a
theme at the annual NHS Research and Development
Forum (NHS RD Forum) Conferences in 2016 and 2017.
The need to reduce waste in NHS research was first
highlighted in 2009 by Chalmers and Glasziou [2]. Using
consistent criteria for evaluation they estimated that 85%
health research was potentially wasted representing a
significant element of the approximate global spend of
$200 billion on health related research [4]. Principally,
the waste is judged to be attributable to failure to pub-
lish research, unclear reporting of research that is pub-
lished, and the failure of new research studies to
systematically review previous research in the same topic
area. 50% of registered clinical trials were not published
in full; 50% of published reports did not fulfil the criteria
for clear, accurate and complete reporting; 50% of new
studies failed to take into account evidence and results
from previous research. Waste was also attributable to
poor study design and conduct which usually means re-
search study question topics are replicated unnecessarily.
The Lancet series of articles in 2009 and 2014, and fur-
ther review in 2016, primarily focused on the actions and
responsibilities of research funders, regulators, journals,
academic institutions, and researchers in reducing waste
([1–3, 5, 6, 9, 14]). The growth of patient and public in-
volvement and engagement (PPIE) in health and social
care research over the last decade suggests there is another
important stakeholder group who may have a role to play.
As patients and the public play an increasing role as co-
applicants for research funding, on study advisory and
management groups, and as co-researchers, then they
have an interest and responsibility to ensure that the re-
search they are engaged in is high quality, well designed
and ultimately is of benefit to patients.
Background
As part of a wider programme of work on reducing
waste in health and care,1 a review of the literature on
waste in healthcare [10, 11], found waste in research was
listed amongst the main categories of waste in health
care expenditure and could be identified in a number of
areas including:
 Prioritisation of research;
 Assessment of evidence;
 Design, conduct and analysis of research;
 Research taking place to time and target;
 Patient and public involvement;
 Regulation and management of research;
 Publication and dissemination;
 Implementation of research;
 Misconduct and fraud;
 Administration;
 Use of research funding;
 Costing of studies; [1–3, 5, 6, 9].
‘Difficult conversations? Engaging patients in reducing
waste in the commissioning and delivery of health care’
[12], examined the potential role of patients in reducing
waste recommended taking the learning from PPIE to
engage in dialogue and partnership in the reduction of
waste. This recommendation also has resonance for the
reduction of waste in research.
Since 2009 those working across the research pathway
in the UK, in particular the National Institute for Health
Research (NIHR), have made huge progress in tackling
waste and ensuring research provides value for money.
The NIHR developed the Adding Value in Research
framework to help researchers who are submitting appli-
cations for funding [16]. They also facilitated the setting
up of an international funders group to develop and
share good practice and guidance. Similarly networks
such as the REWARD Alliance (www.rewardalliance.net)
and EQUATOR (www.equator-network.org), provide
platforms to share information and resources for aca-
demics and researchers to improve the quality of re-
search and reporting. Of the international funding
bodies, the NIHR and ZonMW of the Netherlands were
the most developed in terms of involving patients and
the public in their decision making. Only the NIHR re-
quires the consideration of systematic reviews in funding
applications and just over half the funders require publi-
cation of full reports of the research funded [15]. How-
ever, the role of patients and the public, who engage in
the research process as co-applicants, project team
members or co-researchers, in addressing research waste
and implementing the Adding Value in Research Frame-
work has not been considered in any depth.
A workshop held in May 2016 at the annual NHS RD
Forum conference, in conjunction with NIHR Evaluation,
Trials and Studies Coordinating Centre (NETSCC), which
aimed to understand the role and influence of NHS R & D
and governance managers in promoting the reduction of
research waste, identified strong interest from patient par-
ticipants. Further consultation with two expert patient
research groups (a working group of the NHS RD Forum
and a public involvement group in the North West) post
conference confirmed that waste in research was also of
interest to patients and they wished to participate in the
project. In order to understand their perspective it was
agreed that they would complete a similar survey to the R
& D management community and that the RD Forum
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Service User and Carer Working Group (SUCWG) would
also act as critical friends on the project aiming to under-
stand the role and influence of R & D managers. The
SUCWG are a working group of the RD Forum providing
support and advice on user engagement in the research
process and have a good understanding of the role of re-
search management and regulation as well as extensive
experience of research. They therefore had expertise to
draw on to critically review the project.
In order to capture the perspective of patients and
carers, and triangulate this with the data from the R & D
management community, a separate survey was sent to
three expert patient research groups. The survey used
the same questions and format as the R & D manage-
ment community survey and was sent out, with that sur-
vey, in September 2016. The aim of the NHS R & D
management community survey was to identify their in-
fluence in ensuring research provided value and better
outcomes for patients. The aim of the similar survey for
PPIE representatives was to assess their understanding
and influence in the area of research waste. The aims
differed slightly as the responsibility of NHS R & D
managers in reducing waste was to some extent identi-
fied in the Adding Value in Research Framework [16].
However, the role and influence of PPIE representatives
in research waste had not been explored at all and was a
new topic. The groups asked to participate were the
PPIE members of the NHS RD Forum SUCWG, Black-
pool patient research group, and the NIHR Patient Re-
search Ambassadors (PRAs). Although the SUCWG and
Blackpool patient group had a defined membership of
approximately ten people each, it was harder to define
the number of PRAs. PRAs self-define and register with
the PRA project but the actual number at the time of
the study, and in receipt of the survey, was unknown.
There were nineteen respondents to the survey and
many of them fulfilled a variety of public involvement
research roles including patient research ambassador, in-
dependent consultant, review panel, study or trials steer-
ing group member, member of the RD Forum SUCWG,
and lay researcher (see Fig. 1).
Methodology
The unique perspective of the PPIE community in the re-
search process meant it was important to confirm their
understanding of the main areas of waste as identified in
the literature. The workshop held at the NHS RD Forum
conference in May 2016 included patient representatives
and supported this course of action. An electronic survey
was designed and issued in September 2016, to three PPIE
research groups. The purpose of the survey was to dis-
cover the PPIE communities understanding of the main
areas of research waste. Questions asked whether
respondents agreed or disagreed with the categories
of research waste identified in the literature, which
categories they thought were most important to ad-
dress, which would add the most value if addressed,
which areas of waste they thought they would be able
to influence and what barriers they may encounter.
The categories of research waste presented in the sur-
vey (see Appendix 1) were those identified in the Lancet
series of articles [1–3, 5, 6, 9]. See also Appendix 2 for
further explanation of the meaning and interpretation of
the different categories.
Findings
The main categories of research waste identified, from
the list presented to survey recipients, were (weighted
and ordered according to the number of respondents
who strongly agreed or agreed):
 Implementation of research in practice
 Publication and dissemination
 Prioritisation of research
 Patient and public involvement
 Administration
 Research taking place to time and target
 Design, conduct and analysis of research
 Assessment of evidence
 Costing of studies.
Other categories of potential research waste that were
identified included a lack of PPIE in setting priorities,
poor use of inter-disciplinary collaboration and Univer-
sity on-costs.
Asked to identify the most important categories of re-
search waste to address, on a scale of one to ten with one
being the most important, respondents selected prioritisa-
tion of research as the most important (i.e. decisions about
what research should be carried out and funded). Scores
for the other categories were fairly evenly spread. The
Fig. 1 Public involvement roles
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categories seen as least important were misconduct and
fraud, administration, and costing of studies.
When asked to identify the categories of waste that
would add most value to the research process if addressed,
the responses were slightly different to the question about
importance. Respondents identified prioritisation of re-
search and patient and public involvement. Other scores
were fairly evenly distributed. The areas that would gene-
rate the least value if addressed were identified as regu-
lation and management of research, misconduct and
fraud, research taking place to time and target, and costing
of studies.
Patients involved in PPIE felt that the areas they could
influence were (in order of frequency):
 Patient and public involvement
 Design, conduct and analysis of research
 Prioritisation of research
They felt they could least influence research taking
place to time and target, regulation and management of
research, misconduct and fraud, and costing of studies.
The barriers to PPIE influence, suggested by respon-
dents, were identified as:
 Not being taken seriously; tokenism;
 The low status of PPIE;
 Power imbalances;
 Lack of clarity of PPIE role;
 PPIE members’ lack of knowledge of aspects of the
research process and the NHS;
 Dynamics of academic institutions.
Power imbalances were seen as leading to tokenism
with one respondent pointing to experience of being the
only PPI representative amongst a group of professionals
who considered themselves ‘experts’. Another respond-
ent suggested academic institutions afforded low status
and a lack of respect to PPI and did not welcome
challenge to their culture and leadership.
Discussion
Public involvement in research and public engagement
and awareness of research has grown in recent years.
This followed campaigns to raise public awareness and
the publication of material such as ‘Bad Pharma’ and
‘Deadly Medicines’ ([7, 8]). It was also a result of the in-
creasing number of patients engaged in NIHR activities
and awareness raising by research charities. There is a
responsibility on researchers to ensure their research
provides value for money. Patient co-applicants, project
team members or co-researchers accept this responsibil-
ity when taking on that role.
This sample of the PPIE community agreed that waste
in research was an important area to address, particu-
larly in the areas of prioritisation of research and patient
and public involvement. However, it should be noted
that the three groups involved had experience of in-
volvement in research and PPIE and may have had more
knowledge than a less experienced group. The survey
also took a small sample so only offers a snapshot of the
PPIE community and an indication of the potential for
PPIE in research waste.
A comparison of the data with that resulting from the
survey of the R & D management community showed
that the R & D management community tended to iden-
tify more areas of research waste they perceived as im-
portant, and that they could influence, than PPIE
respondents. They identified implementation of research
in practice, prioritisation of research, and research taking
place to time and target as the most important and valu-
able areas of waste to address. Within the areas of im-
plementation of research and prioritisation of research
there were specific references to PPIE and where public
involvement could be strengthened in order to reduce
research waste. These focused on improved engagement
with patients. Lack of PPIE, and research not being led
by patients or addressing their priorities, was also identi-
fied as a factor in implementation of research in prac-
tice. Patient and public engagement in prioritisation was
seen as an important element in increasing the relevance
of research. Lack of patient engagement and stakeholder
communication was also linked to inappropriate design
and relevance. It follows that increased stakeholder and
patient engagement, to ensure the design was the right
design, can lead to improvements. The recognition of
both groups of the importance of PPIE in reducing waste
and improving the quality of research provides strength to
the drive for more co-production in the research process.
Conclusions
Respondents to the survey had some understanding of
the main categories of research waste but felt their influ-
ence in reducing that waste was currently limited. The
main areas of waste identified by both respondents in
the PPIE and R & D community surveys were prioritisa-
tion of research and PPI. There could be opportunities
for the R & D management community to engage with
patients on both these areas.
Patients undertake key roles in the research process
including co-applicancy, project management, and as co-
researchers, and this brings responsibility for ensuring
high quality research and value for money. Responsibility
for recognition of the potential for wasteful practices is
part of the conduct and operation of research studies.
To overcome the barriers to PPIE influence, PPIE
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representatives need to be supported to enable them to
recognise and challenge wasteful practices. This could be
in the form of awareness raising and training for those
undertaking the role of co-applicant, project team mem-
ber or co-researcher. A number of PPIE representatives
already play an important role in ensuring only high qual-
ity research is prioritised and funded through the James
Lind Alliance priority setting partnerships and the NIHR
funding panels. Building awareness of those opportunities
for engagement would be a useful starting point.
The report ‘NHS Research and Development Manage-
ment Community: Adding Value, Reducing Research
Waste’ (Minogue and Wells June 2017 [13]) recommended
that research and development community stakeholders
work together to coordinate activity to address the actions
identified in the report. Patients are members of this com-
munity and should be engaged in this work going forward.
They play a key role in the work of the NIHR and the NHS
RD Forum and could be engaged through the work streams
currently being led by those organisations. Examples of
these are the NIHR Adding Value Framework, the develop-
ment of guidelines by the international funders group, and
the RD Forum working groups.
Endnotes
1The NHS wide Future Focused Finance programme has
a work stream focused on reducing waste with a specific
aim to increase citizen awareness. A further aim focuses
on working with the NIHR and NHS RD Forum to reduce
waste in research. www.futurefocusedfinance.nhs.uk
Appendix 1 Survey Questions
Categories of research waste
1. The following categories of waste in research have
been identified, please say whether you agree or










○ ○ ○ ○ ○
Evidence not being
considered
○ ○ ○ ○ ○
Flawed design,
conduct, analysis
○ ○ ○ ○ ○
Research not taking
place to time and
target
○ ○ ○ ○ ○
Patient and public
involvement












○ ○ ○ ○ ○
Publication and
dissemination
○ ○ ○ ○ ○
Implementation of
research in practice
○ ○ ○ ○ ○
Misconduct and
fraud
○ ○ ○ ○ ○
Administration ○ ○ ○ ○ ○
Use of research
funding
○ ○ ○ ○ ○
Poorly costed
studies
○ ○ ○ ○ ○
Other ○ ○ ○ ○ ○
If you answered ‘other’ please give details of any other
area of waste you know about.
2. Which of the areas of research waste listed are, in
your view, the most important to address? Please
identify your top six areas ranking from 1 to 6 in
order of importance.
If you answered ‘other’ to the previous question please
give reasons for your answer.
3. Which categories of waste do you feel provide
the opportunity to have the biggest impact on
research if they are addressed? Please identify
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your top six areas ranking from 1 to 6 in order
of importance.
If you answered ‘other’ to the previous question please
give reasons for your answer.
Your role
4. Which categories of research waste do you feel you








Prioritisation of research ○ ○ ○ ○
Evidence not being
considered
○ ○ ○ ○
Flawed design, conduct,
analysis
○ ○ ○ ○
Research not taking place
to time and target
○ ○ ○ ○
Patient and public
involvement
○ ○ ○ ○
Regulation and
management of research
○ ○ ○ ○
Publication and
dissemination
○ ○ ○ ○
Implementation of research
in practice
○ ○ ○ ○
Misconduct and fraud ○ ○ ○ ○
Administration ○ ○ ○ ○
Use of research funding ○ ○ ○ ○
Poorly costed studies ○ ○ ○ ○
Other ○ ○ ○ ○
If you answered ‘other’ please give reasons for your
answer.
5. What do you see as the barriers to service users and
carers being able to influence waste in research?
About you
Please indicate which best describes your role from the
list below (tick any that apply)
6. Are you a:
 Patient research ambassador
 Member of a patient review panel for an NHS trust
 Member of a NIHR research panel
 Member of the RD Forum service user and carer
working group




 Member of a Research Ethics Committee
 Other
If ‘other’ please specify.
Appendix 2 – categories of research waste
Prioritisation of research - decisions about what research
should be carried out and funded based on the needs of
the potential users of research evidence and other
stakeholders. Waste occurs when the needs of users are
ignored and the findings of previous studies are not
taken into account.
Assessment of evidence - Researchers consider and
systematically assess evidence from previous research in
designing a study and take account of the findings and
results from related research. Waste occurs when
findings are ignored, research is replicated, or time is
wasted submitting funding applications not taking into
account previous evidence. Design, conduct and analysis
of research - Poorly designed or biased studies can lead
to useless data and misleading results. Methodologies
which do not answer the questions will also lead to
flawed data. Poorly trained researchers can also lead to
flawed methodologies, analysis and reporting resulting in
wasted research.
Research taking place to time and target – The
introduction of measures to ensure recruitment to studies
within a defined period after study commencement aims
to reduce time wasted in studies. Sometimes this has led
to a rush to recruit rather than focusing on good set up
and performance.
Patient and public involvement; PPI is a requirement of
many different aspects of research including applications
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for funding, prioritisation of research and research design.
Not engaging patients and the public can lead to poor
prioritisation, poor design, inappropriate methodology,
insufficient PPI, and poor use of funding.
Regulation and management of research refers to
waste occurring through inefficient management, the
burden and inconsistent application of regulation and
standards of research.
Publication and dissemination; Approximately half of
health research undertaken is not published [6, 17]
therefore the results are not made available to others
nor does the work contribute to knowledge. This
represents a waste of research funding and means other
researchers cannot consider this evidence when designing
their own studies which may lead to further waste.
Implementation of research; not only is research not
published, it is sometimes not disseminated to
stakeholders with an interest in the topic area. This
means they are unable to consider the evidence and use
it to change practice and improve services. As research
can take many years to reach the implementation phase
it is not always timely in terms of service development
and the commissioning of services.
Misconduct and fraud; Waste through misconduct and
fraud can occur when research data is fabricated,
falsified or mispresented. It can also occur if the
research protocol is not followed or if good clinical
practice for research is not adhered to.
Administration; waste can occur where there is
duplication of processes and procedures within one or
more organisations or where processes are overly
bureaucratic.
Use of research funding; Waste can occur where there is
a lack of understanding of research funding, costing and
cost attribution which can lead to poorly costed studies,
poor use of funding and duplication of processes.
Costing of studies; lack of knowledge and not engaging
people with financial expertise can lead to poorly costed
studies and inefficient use of research funding.
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